Why is Torrent Pharma falling/rising?

As of 24-Jul, Torrent Pharmaceuticals Ltd. is experiencing a decline in its stock price, currently at 3,507.05, reflecting a decrease of 47.0 points or 1.32%. The stock has underperformed its sector today by 1.67%, despite trading above its moving averages across various time frames. Over the past month, Torrent Pharma has shown a positive return of 10.38%, significantly outperforming the Sensex, which only increased by 0.16%. However, the company is facing a decrease in investor participation, with delivery volume falling by 10.65% against the 5-day average. While the company has demonstrated high management efficiency and consistent returns over the last three years, concerns about poor long-term growth and high valuation metrics may be contributing to the recent price decline.
In the broader market context, Torrent Pharma's short-term performance is slightly better than the benchmark, with a 1-week return of -0.08% compared to the Sensex's -0.09%. Despite the stock's recent struggles, it has shown strong performance over longer periods, including a 12.23% return over the past year, which is significantly higher than the Sensex's 2.54%. The company's high institutional holdings suggest confidence among knowledgeable investors, yet the stock's expensive valuation and modest sales growth could be causing caution among retail investors, leading to the current downward pressure on the stock price.